Document and Entity Information
Document and Entity Information | Oct. 06, 2022 |
Document And Entity Information [Line Items] | |
Security Exchange Name | NASDAQ |
Amendment Flag | false |
Entity Central Index Key | 0001847903 |
Document Type | 8-K |
Document Period End Date | Oct. 06, 2022 |
Entity Registrant Name | CENTESSA PHARMACEUTICALS PLC |
Entity Incorporation State Country Code | X0 |
Entity File Number | 001-04321 |
Entity Tax Identification Number | 98-1612294 |
Entity Address, Address Line One | 3rd Floor |
Entity Address, Address Line Two | 1 Ashley Road |
Entity Address, Address Line Three | Altrincham |
Entity Address, City or Town | Cheshire |
Entity Address, Postal Zip Code | WA14 2DT |
Entity Address, Country | GB |
City Area Code | +44 7391 |
Local Phone Number | 789784 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Fair Value Measured at Net Asset Value Per Share [Member] | |
Document And Entity Information [Line Items] | |
Security Exchange Name | NASDAQ |
Security 12b Title | Ordinary shares, nominal value £0.002 per share |
Trading Symbol | CNTA |
Adr [Member] | |
Document And Entity Information [Line Items] | |
Security Exchange Name | NASDAQ |
Security 12b Title | American Depositary Shares, each representing one ordinary share, nominal value £0.002 per share |
Trading Symbol | CNTA |